SEC Form 4 · accession 0001140361-15-022472
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne Reiser
Officer — President - ResMed EMEA-APAC
Period of report
May 27, 2015
Accepted (ET)
May 29, 2015 · 9:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | May 27, 2015 | M | 3,000 | $17.30 | A | 71,120 | D | |
| ResMed Common StockF2,F3 | May 27, 2015 | S | 3,000 | $57.907 | D | 68,335 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed NQ Stock Options | $17.30 | May 27, 2015 | M | 3,000 | D | Nov 24, 2012 | Nov 24, 2015 | ResMed Common Stock | 3,000 | 9,000 | D |
Explanation of responses
- F1The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
- F2This transaction was executed in multiple trades at prices ranging from $57.90 to $57.92. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.
- F3Includes 214.657 shares of ResMed stock purchased on April 30, 2015, through the Employee Stock Purchase Plan.